Annual Meeting and Educational Conference
SEPTEMBER 18-20, 2017
WASHINGTON, DC
 

CE Satellite Symposia - Breakfast and Lunch Provided

Maryland Room
Located on the Lobby Level of Marriott Wardman Park


Tuesday, September 19, 2017
, 7:00 - 8:00 AM
Title: Improving Outcomes in Cystic Fibrosis: Role of the Specialty Pharmacist

Description: This session will review the guidelines for screening and diagnosing patients with cystic fibrosis (CF) and highlight how to appropriately identify patients who qualify for CFTR modulator therapy. Specialty pharmacists are in the perfect position to have consistent communication with patients with CF as well as with other healthcare providers, including the prescribing physician and the health-system/center for excellence CF pharmacist. The specialty pharmacist may be the last healthcare professional the patient will interact with prior to taking their medication, and so counseling on adherence to therapy will play a large part in the day to day activities. This activity will focus on information on the newest CF therapies and provide best practices for patient education on CF and how to help improve patient access for these therapies.

For more information, click here.


Wednesday, September 20, 2017, 7:00 - 8:00 AM
Title: Atopic Dermatitis: A Specialty Pharmacy 360-Degree View of the Patient

Description: With the advent of new agents for Atopic Dermatitis (AD) moving through specialty pharmacy channels, specialty pharmacists are suddenly at the hub of stakeholders in the treatment of AD. This activity will provide an overview of AD, including an introduction to the impact of inadequately treated moderate-to-severe disease and details of current and emerging therapies. The ways in which specialty pharmacists can work as part of multidisciplinary AD teams, actively engage in shared decision-making with patients, and reduce treatment barriers to increase value will be highlighted.

For more information, click here.

 

Wednesday, September 20, 2017, 12:00 - 1:00 PM
Title: Optimizing Hepatitis C Disease Management: Implications for Specialty Pharmacy

Description: HCV remains a highly prevalent, extremely costly disease. Specialty pharmacists have a significant role in helping HCV patients achieve individualized treatment goals. This CE activity will present strategies to support treatment adherence, navigate cost issues, manage special populations, and ensure optimal patient outcomes.

For more information, click here.



For registration assistance, please email info@naspmeeting.com, or call +1 (888) 949-2964 between 9:00 am and 5:00 pm US EDT.